Matches in SemOpenAlex for { <https://semopenalex.org/work/W2273450130> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2273450130 endingPage "1795" @default.
- W2273450130 startingPage "1791" @default.
- W2273450130 abstract "Cisplatin has proven to be the most active single agent in the treatment of metastatic and recurrent squamous cell cancer of the cervix. In a previous southwest Oncology Group (SWOG) pilot study, the addition of cisplatin to a mitomycin-C, vincristine, and bleomycin (MVB) regimen resulted in a relatively high percentage of durable complete responses. To gain more experience with cisplatin-based chemotherapy regimens, the SWOG initiated a phase II randomized trial of cisplatin, mitomycin-C plus cisplatin (MC), and MVB plus cisplatin (MVBC) in 119 patients with advanced squamous cell cancer of the cervix and no prior chemotherapy exposure. Because of slow patient accrual early in the trial, the cisplatin arm was discontinued. Five patients were declared ineligible according to protocol criteria. The three treatment groups were relatively well matched for age, prior radiation exposure, and sites of measurable disease. The overall objective response rates for cisplatin, MC, and MVBC treated patients were 33%, 25%, and 22%, respectively. Median response durations were greater than 6 months. Median survival durations associated with cisplatin, MC, and MVBC treatment were 17.0, 7.0, and 6.9 months, respectively. There were no drug-related deaths. Severe or life-threatening leukopenia and thrombocytopenia were observed in 18% to 24% of patients treated with MVBC and MC, but in none of those receiving cisplatin alone. We conclude that the low response rates and short durations of both response and survival observed in patients randomized to the two chemotherapy combinations suggest that only enhanced toxicity was gained through the addition of mitomycin-C or MVB to cisplatin in patients with advanced cervix cancer." @default.
- W2273450130 created "2016-06-24" @default.
- W2273450130 creator A5023121371 @default.
- W2273450130 creator A5029541691 @default.
- W2273450130 creator A5043099596 @default.
- W2273450130 creator A5043337092 @default.
- W2273450130 creator A5059477836 @default.
- W2273450130 creator A5066615143 @default.
- W2273450130 creator A5077232908 @default.
- W2273450130 date "1987-11-01" @default.
- W2273450130 modified "2023-10-17" @default.
- W2273450130 title "Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study." @default.
- W2273450130 cites W1926137745 @default.
- W2273450130 cites W195397358 @default.
- W2273450130 cites W2401644698 @default.
- W2273450130 cites W2409392632 @default.
- W2273450130 cites W2419358589 @default.
- W2273450130 cites W2425183421 @default.
- W2273450130 doi "https://doi.org/10.1200/jco.1987.5.11.1791" @default.
- W2273450130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2445932" @default.
- W2273450130 hasPublicationYear "1987" @default.
- W2273450130 type Work @default.
- W2273450130 sameAs 2273450130 @default.
- W2273450130 citedByCount "76" @default.
- W2273450130 countsByYear W22734501302012 @default.
- W2273450130 countsByYear W22734501302013 @default.
- W2273450130 countsByYear W22734501302014 @default.
- W2273450130 countsByYear W22734501302015 @default.
- W2273450130 countsByYear W22734501302017 @default.
- W2273450130 countsByYear W22734501302018 @default.
- W2273450130 countsByYear W22734501302021 @default.
- W2273450130 crossrefType "journal-article" @default.
- W2273450130 hasAuthorship W2273450130A5023121371 @default.
- W2273450130 hasAuthorship W2273450130A5029541691 @default.
- W2273450130 hasAuthorship W2273450130A5043099596 @default.
- W2273450130 hasAuthorship W2273450130A5043337092 @default.
- W2273450130 hasAuthorship W2273450130A5059477836 @default.
- W2273450130 hasAuthorship W2273450130A5066615143 @default.
- W2273450130 hasAuthorship W2273450130A5077232908 @default.
- W2273450130 hasConcept C121608353 @default.
- W2273450130 hasConcept C126322002 @default.
- W2273450130 hasConcept C141071460 @default.
- W2273450130 hasConcept C143998085 @default.
- W2273450130 hasConcept C2776694085 @default.
- W2273450130 hasConcept C2776755627 @default.
- W2273450130 hasConcept C2777740455 @default.
- W2273450130 hasConcept C2778220009 @default.
- W2273450130 hasConcept C2778239845 @default.
- W2273450130 hasConcept C2778336483 @default.
- W2273450130 hasConcept C2779338040 @default.
- W2273450130 hasConcept C2779429289 @default.
- W2273450130 hasConcept C2780873365 @default.
- W2273450130 hasConcept C2781413609 @default.
- W2273450130 hasConcept C509974204 @default.
- W2273450130 hasConcept C71924100 @default.
- W2273450130 hasConceptScore W2273450130C121608353 @default.
- W2273450130 hasConceptScore W2273450130C126322002 @default.
- W2273450130 hasConceptScore W2273450130C141071460 @default.
- W2273450130 hasConceptScore W2273450130C143998085 @default.
- W2273450130 hasConceptScore W2273450130C2776694085 @default.
- W2273450130 hasConceptScore W2273450130C2776755627 @default.
- W2273450130 hasConceptScore W2273450130C2777740455 @default.
- W2273450130 hasConceptScore W2273450130C2778220009 @default.
- W2273450130 hasConceptScore W2273450130C2778239845 @default.
- W2273450130 hasConceptScore W2273450130C2778336483 @default.
- W2273450130 hasConceptScore W2273450130C2779338040 @default.
- W2273450130 hasConceptScore W2273450130C2779429289 @default.
- W2273450130 hasConceptScore W2273450130C2780873365 @default.
- W2273450130 hasConceptScore W2273450130C2781413609 @default.
- W2273450130 hasConceptScore W2273450130C509974204 @default.
- W2273450130 hasConceptScore W2273450130C71924100 @default.
- W2273450130 hasIssue "11" @default.
- W2273450130 hasLocation W22734501301 @default.
- W2273450130 hasLocation W22734501302 @default.
- W2273450130 hasOpenAccess W2273450130 @default.
- W2273450130 hasPrimaryLocation W22734501301 @default.
- W2273450130 hasRelatedWork W1448091729 @default.
- W2273450130 hasRelatedWork W1511187821 @default.
- W2273450130 hasRelatedWork W1920766498 @default.
- W2273450130 hasRelatedWork W2357273538 @default.
- W2273450130 hasRelatedWork W2361544313 @default.
- W2273450130 hasRelatedWork W2367148332 @default.
- W2273450130 hasRelatedWork W2392383546 @default.
- W2273450130 hasRelatedWork W2411306717 @default.
- W2273450130 hasRelatedWork W2419081241 @default.
- W2273450130 hasRelatedWork W3149210031 @default.
- W2273450130 hasVolume "5" @default.
- W2273450130 isParatext "false" @default.
- W2273450130 isRetracted "false" @default.
- W2273450130 magId "2273450130" @default.
- W2273450130 workType "article" @default.